Covid-19. China approves patent for vaccine “that can be produced in a short period of time”

News Snapshot:

by drbyos The project is in the third testing phase, the last one before its implementation, and was developed by the Instituto Científico Militar and the Chinese biopharmaceutical company CanSino Biologics. The vaccine began to be used in late June in the Chinese Army, after a team led by researcher Chen Wei discovered a highly efficient neutralizing monoclonal antibody. After these tests, countries like Saudi Arabia, Russia and Chile offered to carry out the latest vaccine trials. Unlike the Russian vaccine – which is believed to have been approved without starting the third phase of testing and whose investigation has...